Specialist and experienced pricing and market access consultancy
We will develop and implement a successful launch strategy for your product.
We build payer focussed pricing and market access strategies to enable commercial success.
We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.
Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.
Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.
Individual solutions to suit you
We adapt our working style to reflect your needs
We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies
We react quickly and effectively to provide the best support possible
The pricing benchmark has shifted faster than systems have adapted. In the UK, prices for one-time t…
Read moreSuccessfully navigating early payer scientific advice whether through Joint Scientific Consultations…
Read moreNICE has introduced important appraisal reforms for 2025 that will directly impact manufacturers pre…
Read morePreparing a NICE submission can feel overwhelming. Whether it’s a Single Technology Appraisal (STA…
Read moreIn 2010, the world’s most expensive therapy was Soliris (eculizumab), costing around USD 409,500 p…
Read moreFive success pillars — your JCA evidence-generation checklist From 12th January 2025, the Eu…
Read moreA €3 million invoice for a single infusion can dazzle as easily as it alarms. Gene therapies such …
Read moreProving the long-term value of pharmaceutical assets remains one of the biggest challenges for manuf…
Read moreTo date, there are two different levers in play under Trump’s “Most Favored Nation”, 1. A drug…
Read more